The E5 oncoprotein of bovine papillomavirus type 1 is a Golgi-resident, hydrophobic polypeptide that can transform immortalized ®broblasts by activating endogenous platelet-derived growth factor receptor b (PDGF-R). However, the existence of E5 mutants that dissociate transformation from PDGF-R activation implies that there are additional mechanism(s) by which E5 can transform cells. We now show that both wt E5, and transforming E5 mutants that are defective for PDGF-R activation, constitutively activate endogenous c-Src in NIH3T3 cell lines to levels normally associated with acute growth factor stimulation. The ubiquitous Src family protein tyrosine kinase (PTK) Fyn is not activated by these E5 constructs, nor are focal adhesion kinase and endogenous receptor PTKs for insulin, epidermal growth factor, basic ®broblast growth factor and insulin-like growth factor. We further demonstrate that transforming activity of the L26A E5 mutant, which is highly defective for PDGF-R activation, depends on its ability to activate Src. L26A E5 does not transform SYF cells that are de®cient for Src, Fyn and Yes, unless Src expression is reconstituted, and does not transform NIH3T3 cells in which Src PTK activity is maintained at a basal level by means of kinase-defective K295R Src overexpression.
Introduction
Papillomaviruses are double-stranded DNA tumor viruses that induce benign and malignant neoplasia in a range of vertebrate hosts, including cervical carcinoma in humans (Lancaster and Olson, 1982; Schiman et al., 1993; Bosch et al., 1995) . Bovine papillomavirus type 1 (BPV-1) induces ®bropapillomas in cattle (Lancaster and Olson, 1982) and has been used as a model system to study papillomavirus-induced transformation in vitro Lowy et al., 1980; Meischke, 1979; Chen et al., 1982) .
The major transforming protein encoded by BPV-1 is E5 (Yang et al., 1985; Schiller et al., 1986; Gro and Lancaster, 1986; DiMaio et al., 1986) , a 44-amino acid, hydrophobic polypeptide that has no intrinsic enzymatic activity (Stoppler et al., 1994; DiMaio et al., 2000) . E5 is localized primarily in membranes of the Golgi apparatus (Burkhardt et al., 1989) , and targeting of E5 to the trans-Golgi compartment appears to be necessary for cellular transformation . E5 stably associates with the platelet-derived growth factor receptor b (PDGF-R) (Petti and DiMaio, 1992; Drummond-Barbosa et al., 1995) , the 16 kDa pore-forming subunit of the vacuolar H + -ATPase (Goldstein et al., 1991) , and an a-adaptin-like protein (Cohen et al., 1993) . Transformation is thought to result from the trans-phosphorylation and sustained activation of PDGF-Rs that form a complex with E5 dimers (Petti et al., 1991; Goldstein et al., 1994; Drummond-Barbosa et al., 1995; Lai et al., 1998; Klein et al., 1998) . However, while PDGF-R activation has a role in mediating cellular transformation by wild-type (wt) E5, transforming E5 mutants have been described that minimally activate the PDGF-R because they are defective for PDGF-R binding (Sparkowski et al., 1996; Adduci and Schlegel, 1999) or dimerization (Adduci and Schlegel, 1999) . The existence of two dierent classes of E5 mutants that dissociate transformation from PDGF-R activation implies that there is an additional pathway(s) by which E5 can transform cells.
We recently have shown that wt E5, and transforming E5 mutants that are defective for PDGF-R activation, constitutively activate heterodimeric (p85/p110) phosphoinositide 3-kinase (PI 3-K). Since constitutively active PI 3-K has been shown to induce characteristics of cellular transformation (Chang et al., 1997; Klippel et al., 1998) , it is conceivable that PI 3-K activation contributes signi®cantly to E5-dependent transformation. Furthermore, a protein tyrosine kinase (PTK) distinct from the PDGF-R appears to be activated by E5, since E5-dependent PI 3-K activation is correlated with tyrosine phosphorylation of the PI 3-K p85 regulatory subunit, but does not parallel levels of PDGF-R activation . Oncogene (2002) 21, 1695 ± 1706 Numerous receptor PTKs can activate PI 3-K via tyrosine phosphorylation of its p85 subunit (Shepherd et al., 1998; Solto et al., 1992) . In addition, PI 3-K has been detected in complexes with non-receptor PTKs, including focal adhesion kinase (FAK) and the Src family PTKs Src, Fyn, Lyn, Abl, and Lck (Gutkind et al., 1990; Varticovski et al., 1991; Liu et al., 1993; Prasad et al., 1993; Vogel and Fujita, 1993; Chen and Guan, 1994; Pleiman et al., 1994) . These interactions also can induce p85 tyrosine phosphorylation and PI 3-K activation (Varticovski et al., 1991; Liu et al., 1993; Chen and Guan, 1994; Pleiman et al., 1994) . Since PTKs typically are oncogenic when overexpressed or constitutively active (Cadena and Gill, 1992; Hunter, 1997; Jones et al., 2000; Irby and Yeatman, 2000) , the present study was undertaken to identify PTK(s), other than the PDGF-R, that are constitutively activated by E5, and to determine their role in E5-dependent transformation. We show that both wt E5, and transforming E5 mutants that are defective for PDGF-R activation, constitutively activate Src in NIH3T3 cells, but do not activate endogenous receptors for insulin, epidermal growth factor (EGF), ®broblast growth factor (FGF) and insulin-like growth factor (IGF), or the non-receptor PTKs Fyn and FAK. We further show that transforming activity of the L26A E5 mutant, which is highly defective for PDGF-R activation, depends on its ability to activate Src. Surprisingly, PI 3-K activation by E5 occurs independently of Src, and is not sucient to induce transformation.
Results

Analysis of receptor PTK activation
To identify endogenous growth factor receptor PTKs in NIH3T3 cells, puri®ed growth factors were tested for their ability to induce cell proliferation in reducedserum medium containing 0.5% fetal bovine serum (FBS). Under these conditions, the number of cells increased by only 20% over a period of 3 days unless additional growth factors were provided. As shown in Figure 1a , additions of EGF or IGF stimulated proliferation 411-fold, PDGF and insulin increased proliferation 414-fold, and basic FGF elicited a 33-fold increase in growth. Acidic FGF failed to induce proliferation, even in the presence of heparin (data not shown). Therefore, the 3T3 cells used in this study possess functional receptors for PDGF, insulin, EGF, basic FGF and IGF.
The ability of wt BPV-1 E5 to induce tyrosine phosphorylation and sustained activation of the PDGF-R is well documented (Petti et al., 1991; Goldstein et al., 1994; Drummond-Barbosa et al., 1995; Lai et al., 1998) . We investigated whether wt E5 and several transforming E5 mutants that are defective for PDGF-R activation (Table 1) can cause persistent activation of other endogenous receptor PTKs by measuring levels of receptor tyrosine phosphorylation in the absence of growth factors. For this analysis, tyrosine-phosphorylated proteins were immunoprecipitated from serum-starved 3T3 cell lines expressing E5 constructs, and were immunoblotted with antibodies recognizing individual receptor PTKs. The cells were lysed in the presence of SDS and immediately boiled to minimize the possibility of proteolysis or post-lysis changes in phosphorylation. Boiling in SDS also served to disrupt protein-protein interactions, so that the immunoblots measured levels of tyrosine-phosphorylated receptors, and not receptors associated with other tyrosine-phosphorylated proteins. As shown in Figure 1b , the insulin receptor b subunit exhibited a low, basal level of tyrosine phosphorylation in serum-starved 3T3 cells, which increased dramatically when insulin was added to the medium for 10 min prior to lysis. However, tyrosine phosphorylation of the b subunit was not elevated in serum-starved 3T3 cell lines that expressed wt E5, or the L26A and L24A transforming E5 mutants (Figure 1b ). This result indicates that the insulin receptor is not activated by E5. Basal levels of tyrosine phosphorylation also were observed for the EGF receptor, FGF receptor and IGF receptor b subunit in serum-starved 3T3 cells, and these phosphorylation levels increased dramatically when EGF, basic FGF or IGF was added to the medium for 10 min (Figure 1c ± e). Wt E5 and L24A E5 did not induce sustained tyrosine phosphorylation of these receptors, and L26A E5 did not enhance tyrosine phosphorylation of the FGF and IGF receptors (Figure 1c ± e). Based on these observations, E5 does not activate FGF and IGF receptors in 3T3 cells.
The intermediate level of EGF receptor tyrosine phosphorylation in L26A E5-expressing cells ( Figure  1c ) apparently derives from receptor autophosphorylation, as it was completely abrogated by 20 mM tyrphostin AG1478 (Figure 4a ), a potent and selective inhibitor of EGF receptor PTK activity (Osherov and Levitzki, 1994; Gazit et al., 1996) . However, if this phosphorylation is indicative of EGF receptor activation, it is unlikely that the activation contributes to cellular transformation, since it was restricted to L26A E5, and was not associated with wt E5 and the L24A transforming E5 mutant (Figure 1c) . Furthermore, EGF receptor signaling does not appear to be involved in PI 3-K activation by L26A E5, since PI 3-K activation was not inhibited by 20 mM tyrphostin AG1478 in L26A E5-expressing cells (Figure 4b ).
Analysis of FAK activation
Cell attachment to the extracellular matrix increases the PTK activity of FAK as a result of integrin engagement and FAK autophosphorylation at Y397 (Burridge et al., 1992; Guan and Shalloway, 1992; Schaller et al., 1994) . Phosphorylated Y397 in turn provides a high-anity binding site for SH2 domains present in Src family kinases and the p85 subunit of PI 3-K, which serves to recruit these proteins to focal adhesions (Guan and Shalloway, 1992; Chen and Guan, 1994; Schaller et al., 1994) . Because the recruitment of p85 by FAK can lead to p85 tyrosine phosphorylation and PI 3-K activation (Chen and Guan, 1994) , we asked whether the activation of PI 3-K by E5 involves E5-dependent FAK activation. To assess FAK activation, FAK tyrosine phosphorylation was measured by immunoprecipitating tyrosine-phosphorylated proteins and immunoblotting with anti-FAK antibodies. As shown in Figure 2a , FAK was highly tyrosine-phosphorylated in exponentially growing 3T3 cells attached to tissue culture dishes, but became dephosphorylated when cells were detached and maintained in suspension for 1 h. The cells remained viable after 1 h in suspension, since replating on tissue culture dishes led to their reattachment and to the tyrosine phosphorylation of FAK at its previous level (Figure 2a) . FAK also was highly tyrosinephosphorylated in adherent cultures of exponentially (e) Anti-phosphotyrosine immunoprecipitates were analysed on Western blots labeled with antibodies recognizing the IGF receptor b subunit.`+IGF' cells were treated with 20 ng/ml IGF for 10 min. All cells in b ± e were treated with 1 mM Na 3 VO 4 for 10 min before lysis Figure 2 Eect of E5 expression on FAK tyrosine phosphorylation in 3T3 cells. (a) Tyrosine-phosphorylated proteins were immunoprecipitated from NIH3T3 cells, or from 3T3 cell lines expressing E5 constructs, and were immunoblotted with anti-FAK antibodies to determine levels of FAK tyrosine phosphorylation. Cells were exponentially growing on 15 cm tissue culture dishes (`+Attachment'), or were detached (trypsin/EDTA treatment) and maintained in suspension for 1 h in spinner¯asks (`7 Attachment'). Control cells were replated on 15 cm tissue culture dishes for 4 h after 1 h in suspension (`7/+Attachment'). Molecular mass markers (in kDa) are indicated on the left. Cells were treated with 1 mM Na 3 VO 4 for 10 min before lysis. The lower molecular weight band was non-speci®cally labeled to the same extent in all lanes. (b) Western blot determination of total FAK in the same cell lysates used for measurements of FAK tyrosine phosphorylation. Each lane contains 100 mg of cell protein, which was TCA precipitated and solubilized in SDS gel sample buer growing 3T3 cell lines that expressed wt E5, or the L26A and L24A transforming E5 mutants, but lost all detectable phosphotyrosine when the cells were placed in suspension for 1 h (Figure 2a) . A control Western blot showed that the cell lines used in these experiments all contained the same total amount of FAK, and that this abundance did not change after 1 h in suspension (Figure 2b ). The fact that E5 does not measurably increase FAK tyrosine phosphorylation in adherent or detached cells strongly argues that FAK is not persistently activated by E5.
Analysis of Src family PTK activation
PI 3-K activation involving tyrosine phosphorylation of its p85 regulatory subunit can result from the association of p85 with Src family PTKs (Gutkind et al., 1990; Varticovski et al., 1991; Liu et al., 1993; Prasad et al., 1993; Vogel and Fujita, 1993; Pleiman et al., 1994) . However, we could not determine whether E5-dependent PI 3-K activation is linked to the activation of one or more Src family PTKs by measuring their phosphotyrosine content, since these PTKs are regulated both positively and negatively by tyrosine phosphorylation (Abram and Courtneidge, 2000) . For example, increased Src PTK activity results from autophosphorylation at Y416, whereas Y527 phosphorylation is inhibitory (Abram and Courtneidge, 2000; Bjorge et al., 2000) . We therefore employed a selective peptide substrate (Cheng et al., 1992) to directly measure the kinase activity of immunoprecipitated Src family PTKs in serum-starved 3T3 cell lines that expressed various transforming and non-transforming E5 constructs.
Acute stimulation of serum-starved 3T3 cells with PDGF for 10 min triggered a 2.3-fold increase in Src PTK activity (Figure 3a) . The same level of Src activation was obtained when cells were treated with 10% FBS for 10 min (data not shown), and has been reported previously for acute stimulation of quiescent cells with PDGF (Ralston and Bishop, 1985; Gould and Hunter, 1988) . The non-transforming Q17G E5 mutant had virtually no eect on Src PTK activity in serum-starved 3T3 cells (1.1-fold increase), however wt E5 and the Q17S, L26A and L24A transforming E5 mutants increased Src PTK activity up to 3.1 fold (Figure 3a) . To demonstrate the speci®city of our Src kinase assay, Src PTK activity also was measured in a 3T3 cell line that expresses constitutively active v-Src, and in mouse ®broblasts that are de®cient for Src, Fyn and Yes (SYF cells; Klinghoer et al., 1999) . As shown (Figure 3a) , serum-starved v-Src-expressing 3T3 cells exhibited a high level of Src PTK activity in the assay (3.7-fold greater than normal 3T3 cells), while serumstarved SYF cells displayed extremely low activity (only 15% of the level in serum-starved 3T3 cells). A Western blot analysis of Src protein levels in these cell Schapiro et al. (2000) . N.D.: not determined Src-dependent transformation by E5 oncoprotein FA Suprynowicz et al lines ( Figure 3a , inset) con®rmed the absence of Src in SYF cells, and showed that v-Src was poorly expressed in the 3T3 cell line (no increase detected above the level of endogenous Src). Interestingly, despite the observed dierences in Src PTK activity in E5-expressing 3T3 cell lines, no dierence was seen in the total amount of Src protein present in the cells (Figure 3a , inset). These results demonstrate that wt E5, and 3 dierent transforming E5 mutants (but not a non-transforming E5 mutant), post-translationally activate c-Src in serum-starved cells to levels normally associated with acute growth factor stimulation. Our observation that L26A E5 induces partial tyrosine phosphorylation of the EGF receptor ( Figure   1c ) prompted us to ask whether the activation of Src by L26A E5 was sensitive to tyrphostin AG1478, a selective inhibitor of EGF receptor PTK activity (Osherov and Gazit et al., 1996) . We found that EGF receptor tyrosine phosphorylation could be eliminated in serum-starved 3T3 cells that express L26A E5 by treatment with 20 mM tyrphostin AG1478 for 60 min (Figure 4a ). Under these conditions, Src PTK activity actually increased by 20%, relative to control L26A E5-expressing cells that were not treated with the inhibitor (Figure 4c) . Therefore, the activation of Src by L26A E5 does not involve EGF receptor signaling. Presumably, E5-dependent Src activation also does not involve PDGF-R signaling, since it is induced by E5 mutants that are defective for PDGF-R activation. Nevertheless, the independence of E5-mediated Src activation from PDGF-R signaling was con®rmed by its insensitivity to 3 mM tyrphostin AG1296, a selective inhibitor of PDGF-R PTK activity (Kovalenko et al., 1994) that blocks the PDGF-R contribution to PI 3-K activation by wt E5 at this concentration . In the presence of 3 mM tyrphostin AG1296, Src PTK activity was increased by 7% in serumstarved 3T3 cells that express L26A E5, and was increased by 53% in cells that express wt E5 ( Figure  4c ).
Among the Src family PTKs, Src and Fyn are ubiquitously expressed (Abram and Courtneidge, 2000) , but exhibit dierent patterns of subcellular tracking and localization. While Fyn associates with the plasma membrane 5 min after synthesis (van't Hof and Resh, 1997), Src becomes associated with membranes 20 ± 60 min after synthesis (van't Hof and Resh, 1997), and localizes predominantly to late endosomal and trans-Golgi compartments (Kaplan et al., 1992) . Since E5 is localized primarily in Golgi membranes (Burkhardt et al., 1989) , and targeting of E5 to the trans-Golgi compartment appears to be necessary for cellular transformation , we investigated the possibility that E5 might not activate Fyn. For this analysis, Fyn was immunoprecipitated from serumstarved 3T3 cells and E5-expressing 3T3 cell lines, and its PTK activity measured in vitro in the manner described for Src.
As shown in Figure 3b , the addition of PDGF to serum-starved 3T3 cells for 10 min increased Fyn PTK activity 1.8-fold; however neither wt E5, nor the transforming L26A and L24A E5 mutants, activated Fyn. In fact, Fyn PTK activity was lower in cells expressing E5 constructs than it was in control 3T3 cells (56% of control for cells expressing wt E5, 63% for L26A E5 and 48% for L24A E5). Fyn PTK activity also was lower in v-Src-expressing 3T3 cells (66% of control); thereby demonstrating that the immunoprecipitation was highly selective for Fyn (Figure 3b) . A Western blot analysis of Fyn protein levels in these cell lines showed that Fyn was slightly less abundant in E5-expressing cells (Figure  3b, inset) . 
Independent activation of PI 3-K and Src by E5
To determine whether Src activation has a role in E5-dependent PI 3-K activation, E5-expressing cell lines were generated from Src7/7, Fyn7/7, Yes7/7 mouse embryonic ®broblasts (SYF cells; Klinghoer et al., 1999) by retroviral infection and selection in puromycin. As a control, E5-expressing lines also were generated from Src+/+, Fyn+/+, Yes+/+®bro-blasts derived from a normal mouse embryo (F wt cells; Klinghoer et al., 1999) . As shown in Figure 5a , the non-transforming Q17G E5 mutant and transforming L26A E5 mutant were expressed at very similar levels in lines derived from both the SYF and F wt cells, and these proteins were not present in the parental cells. This level of E5 expression was somewhat lower than the level in 3T3 cells (Figure 5a) .
In serum-starved F wt cells, the p85 subunit of PI 3-K exhibited a low level of tyrosine phosphorylation, which was not increased by Q17G E5 expression. In contrast, p85 tyrosine phosphorylation was moderately elevated in serum-starved F wt cells that expressed L26A E5 ( Figure  5b ). We previously have demonstrated this eect of transforming E5 constructs on p85 tyrosine phosphorylation in NIH3T3 cells . Serum-starved SYF cells exhibited a slightly higher basal level of p85 tyrosine phosphorylation than F wt cells, and this level was not altered by Q17G E5. However, p85 was heavily tyrosine phosphorylated in serum-starved SYF cells that expressed L26A E5 (Figure 5b ). This result was somewhat surprising, since it implied that Src is not required for the constitutive activation of PI 3-K by a transforming E5 mutant that is defective for PDGF-R activation. Nevertheless, the same result was obtained when PI 3-K activity was directly measured in these cell lines. Relative to control, Q17G E5-expressing cells, PI 3-K activity was moderately elevated by L26A E5 in F wt cells, and was highly elevated by L26A E5 in SYF cells (Figure 5c ). An anti-p85 Western blot indicated that the PI 3-K regulatory subunit was present at the same level in all of the F wt and SYF cell lines (data not shown). These experiments demonstrate that Src, Fyn and Yes are not necessary for E5-dependent PI 3-K activation.
To ascertain whether PI 3-K activity is required for E5-dependent Src activation, L26A E5-expressing 3T3 cells were treated with 2 ± 50 mM LY294002, a speci®c inhibitor of PI 3-K (Vlahos et al., 1994) . The eectiveness of LY294002 for blocking PI 3-K signaling in vivo at these concentrations was con®rmed by measuring intracellular levels of active protein kinase B/Akt (Akt), a well-characterized downstream target of PI 3-K (Burgering and Coer, 1995). Since Akt activation results from its phosphorylation at T308 and S473 by phosphatidylinositol 3,4,5-trisphosphatedependent protein kinases (PDKs; Alessi et al., 1996) , levels of active Akt could be measured on immunoblots labeled with antibodies that recognize Akt only when it is phosphorylated at S473. As shown in Figure 6a , acute stimulation of serum-starved 3T3 cells with FBS caused extensive Akt activation. We also found that Akt was not constitutively activated by L26A E5 in these cells (Figure 6a ). However, active Akt was almost undetectable in L26A E5-expressing 3T3 cells that were treated with 10 or 50 mM LY294002 for 60 min ( Figure  6a) ; thereby demonstrating that PI 3-K signaling is eectively blocked at these inhibitor concentrations. In contrast, even 50 mM LY294002 did not inhibit Src activation by L26A E5 and L24A E5 in serum-starved 3T3 cells (Figure 6b ). Taken together with our analysis of PI 3-K activation in SYF cells, the results obtained using LY294002 show that, in the absence of signi®cant PDGF-R signaling, the constitutive activation of PI 3-K and Src by E5 occur independently of each other.
E5 activation of Src is required for transformation independently of PDGF-R activation
Previous studies have employed E5 oncoprotein mutants to establish the existence of E5 transforming activity that is not linked to PDGF-R activation Tyrosine phosphorylation of the PI 3-K p85 subunit in serumstarved cell lines described in a. Tyrosine-phosphorylated proteins were immunoprecipitated from equal amounts of cell protein and analysed by anti-p85 Western blot. Molecular mass markers (in kDa) are indicated on the left. Cells were treated with 1 mM Na 3 VO 4 for 10 min before lysis. (c) PI 3-K activity of serumstarved F wt and SYF cells expressing Q17G E5 and L26A E5. Thin-layer chromatography was used to detect the phosphorylation of phosphatidylinositol by anti-phosphotyrosine immunoprecipitates in the presence of [g-32 P]ATP. Equal amounts of cell protein were immunoprecipitated for each assay.`PI' and`PIP' indicate the locations of non-radioactive phosphatidylinositol and phosphatidylinositol phosphate standards on the thin-layer plate (Sparkowski et al., 1996; Adduci and Schlegel, 1999; Suprynowicz et al., 2000) . More recently, we have shown that E5 expression leads to the sustained activation of PI 3-K and Src (this study), and that these events do not correlate with the ability of E5 to activate the PDGF-R. Since the constitutive activation of PI 3-K or Src can lead to cellular transformation (Chang et al., 1997; Klippel et al., 1998; Jones et al., 2000; Irby and Yeatman, 2000) , we performed experiments to determine the relative importance of PI 3-K and Src for transformation induced by L26A E5, which exhibits very minimal PDGF-R activation (Adduci and Schlegel, 1999; Suprynowicz et al., 2000) .
Preliminary tests showed that the use of LY294002 to inhibit PI 3-K for extended periods of time blocked cell proliferation (data not shown). Therefore, it was not possible to study E5-dependent transformation in the absence of PI 3-K signaling. To investigate whether L26A E5 can transform cells in the absence of Src signaling, the focus-forming activity of L26A E5-expressing SYF cells was determined using cell mixing experiments (Johnson et al., 1985) , in which a relatively small number of test cells (200) were co-plated with a 7000-fold excess of normal NIH3T3 cells (1.4610 6 ). As shown in Figure 7a , foci did not form when test cells were omitted from the assay, or when SYF cells expressing the non-transforming Q17G E5 mutant were co-plated with 3T3 cells. Moreover, L26A E5-expressing SYF cells also did not generate foci (Figure 7a ), suggesting that Src is required for transformation. To prove that L26A E5 is unable to transform SYF cells because they are de®cient for Src, we generated stable L26A E5 and Q17G E5-expressing lines from SYF cells in which c-Src expression was reconstituted via the retroviral vector pLXSH (SYF+c-Src cells; Klinghoffer et al., 1999). As shown, the E5 mutants were expressed at similar levels in SYF+c-Src cells and SYF cells (Figure 7b ). Most importantly, L26A E5 induced 4200 foci in SYF+c-Src cells, whereas the transformation-defective Q17G E5 mutant induced 510 foci (Figure 7a ). Thus, reconstituting Src expression in SYF cells restored the transforming activity of L26A E5.
Although the focus formation assays involving SYF and SYF+c-Src cell lines demonstrated that Src is required for E5-dependent transformation in the absence of PDGF-R activation, they did not prove that transformation is the direct result of Src activation. It was conceivable that transformation results from the activation of PI 3-K (or an as yet unidenti®ed signaling pathway) by L26A E5 in conjunction with basal Src PTK activity. To discriminate between these possibilities, L26A E5-expressing 3T3 cells were co-transfected with a kinase-defective K295R c-Src point mutant (Bagrodia et al., 1991) and puromycin resistance-conferring vector (pBABEpuro; Morgenstern and Land, 1990) , and were selected in puromycin. Control L26A E5-expressing 3T3 cells were transfected with pBABEpuro alone, and were similarly selected. K295R Src was expressed at a very high level relative to endogenous Src in these cells (Figure 8a) , and functioned as a dominant-negative inhibitor of endogenous Src PTK activity (Figure 8b ). K295R Src inhibited 82% of the increased Src PTK activity induced by L26A E5, but did not decrease Src PTK activity below the basal level found in normal 3T3 cells (Figure 8b ). Src PTK activity was inhibited by only 3% in the control L26A E5-expressing 3T3 cells containing pBABEpuro alone (Figure 8b ). As expected, 3T3 cells that coexpressed L26A E5 and pBABEpuro formed numerous foci (460), while normal 3T3 cells formed very few (510 foci; Figure 8c ). The focus-forming activity of 3T3 cells that coexpressed L26A E5, pBABEpuro and K295R Src was indistinguishable from normal 3T3 cells (510 foci; Figure 8c ). These results show that E5-dependent Src activation is responsible for the PDGF-R-independent transforming activity of E5. In contrast, E5-dependent PI 3-K activation is not sucient to transform cells, since L26A E5 activates PI 3-K in SYF cells (Figure 5c ), and in 3T3 cells that overexpress K295R Src (Figure 8b , inset), without inducing focus formation.
Discussion
The transforming activity of BPV-1 E5 derives in part from its constitutive activation of cellular PDGF-Rs (Petti et al., 1991; Goldstein et al., 1994; DrummondBarbosa et al., 1995; Lai et al., 1998; Klein et al., 1998) . In addition, the existence of E5 mutants that dissociate transformation from PDGF-R activation implies that other signaling protein(s) are activated by E5, and that these contribute to E5-dependent transformation (Sparkowski et al., 1996; Adduci and Schlegel, 1999; Suprynowicz et al., 2000) . In the present study, we have identi®ed c-Src as an additional signaling protein activated by E5 that induces cellular transformation independently of PDGF-R activation.
E5-dependent Src activation
We have employed an in vitro kinase assay, which measures the phosphorylation of a selective peptide substrate by immunoprecipitated Src family PTKs, to show that Src PTK activity is constitutively elevated 2 ± 3-fold in serum-starved NIH3T3 cells that express wt E5. This level of Src activation is signi®cant, as it is equivalent to that observed (Ralston and Bishop, 1985; Gould and Hunter, 1988 , and this study) during acute stimulation of quiescent cells with PDGF. Moreover, we ®nd that E5 can activate Src without concomitant PDGF-R activation: Src is constitutively activated 2 ± 3-fold by transforming E5 mutants that are defective for PDGF-R activation, and the activation of Src by wt E5 is insensitive to the PDGF-R inhibitor tyrphostin AG1296. Src activation appears to be linked to the transforming activity of E5, since Src is not constitutively activated in cells that express the transformation-defective Q17G E5 mutant. Our ®nding that E5 does not increase Src expression indicates that the activation of Src by E5 occurs post-translationally. It is likely that this activation results from changes in the phosphorylation state of Src, . Inset shows tyrosine phosphorylation of the PI 3-K p85 subunit in these cell lines. Tyrosine-phosphorylated proteins were immunoprecipitated from equal amounts of cell protein and analysed by anti-p85 Western blot. Molecular mass marker (in kDa) is indicated on the left. Cells were treated with 1 mM Na 3 VO 4 for 10 min before lysis. (c) Focus forming activities of 3T3 cell lines characterized in a and b were assayed as described in Materials and methods since the participation of Src in mitogenic signaling is primarily regulated in this manner. Most notably, Src autophosphorylation at Y416 increases its PTK activity, while the phosphorylation of Y527 by c-Src kinase (Csk) is inhibitory (Abram and Courtneidge, 2000; Bjorge et al., 2000) . In the future, antibodies that selectively recognize Src which is phosphorylated at these sites should prove useful in elucidating the mechanism of E5-dependent Src activation.
Interestingly, E5 constructs that activate Src do not activate Fyn, a ubiquitously-expressed Src PTK family member which is present in NIH3T3 cells. This dierential activation of Src by E5 may be attributable to dierences in the subcellular distribution of Src and Fyn. Fyn localizes to the plasma membrane in NIH3T3 cells as a result of NH 2 -terminal modi®cation with the fatty acids myristate and palmitate (van't Hof and Resh, 1997). In contrast, the NH 2 terminus of Src contains a cluster of basic amino acids and is modi®ed by addition of a single myristate group (Bjorge et al., 2000) , which directs a signi®cant proportion of Src to associate with late endosomal and trans-Golgi membranes (Kaplan et al., 1992) . E5 is localized primarily in Golgi membranes (Burkhardt et al., 1989) , and targeting of E5 to the trans-Golgi compartment appears to be necessary for cellular transformation . Although we have not speci®cally localized Src in E5-transformed cells, the fact that both proteins independently localize to the trans-Golgi compartment in rodent ®broblasts suggests that E5-dependent Src activation may result from the close proximity of these two proteins in vivo. Nevertheless, a direct physical association between E5 and Src seems unlikely, as we have found that Src does not co-immunoprecipitate with E5 under conditions that preserve the association of E5 with the PDGF-R (unpublished results). Alternatively, the binding of E5 to the 16 kDa pore-forming subunit of the vacuolar H + -ATPase (Goldstein et al., 1991) leads to H + -ATPase inactivation and sustained alkalinization of the trans-Golgi lumen (Schapiro et al., 2000) . Since overexpression of the H + -ATPase 16 kDa subunit signi®cantly inhibits ®broblast transformation by wt E5 (Andresson et al., 1995) , it is possible that trans-Golgi alkalinization in some manner leads to the activation of Golgi-associated Src molecules. In support of this view, it should be noted that the transforming Q17S and L26A E5 mutants induce trans-Golgi alkalinization (Table 1 ) and activate Src (Figure 3a ) in NIH3T3 cells; whereas the non-transforming Q17G mutant does not alkalinize the trans-Golgi lumen (Table  1) and does not activate Src (Figure 3a) . Although the potential signi®cance of Src signaling from the Golgi apparatus has not been determined, a correlation between perinuclear levels of Src and transformation has been reported in breast tissue (Verbeek et al., 1996) .
Src enables E5-dependent transformation independently of PDGF-R activation
The role of constitutively activated Src in cellular transformation is well established (Jones et al., 2000; Irby and Yeatman, 2000) . NIH3T3 cells undergo complete neoplastic transformation when Src PTK activity is constitutively elevated as a result of mouse cSrc overexpression (Lin et al., 1995) . We have not only shown that transforming E5 constructs constitutively activate endogenous c-Src in NIH3T3 cells, but also that Src activation accounts for the transforming activity of E5 that is independent of PDGF-R activation. The L26A E5 mutant, which is highly defective for PDGF-R activation (Adduci and Schlegel, 1999; Suprynowicz et al., 2000) , requires Src in order to transform SYF cells in focus formation assays. Moreover, the increase in Src PTK activity induced by L26A E5 is necessary for transformation: overexpression of the kinase-de®cient K295R Src mutant (Bagrodia et al., 1991) reduces Src PTK activity to a basal level in L26A E5-expressing 3T3 cells, and blocks transformation.
Our discovery that E5 can transform NIH3T3 cells by activating endogenous (mouse) c-Src appears to contradict an earlier ®nding that E5 cannot cooperate with overexpressed chicken c-Src to increase transformation in these cells (Martin et al., 1989) . However, Lin et al. (1995) have shown that complete transformation of NIH3T3 cells can be induced by overexpressed mouse c-Src, but not by overexpressed chicken c-Src. It also has been reported that wt E5 cooperates with overexpressed human EGF receptors and colonystimulating factor 1 (CSF-1) receptors to transform NIH3T3 cells (Martin et al., 1989) . Although we did not investigate CSF-1 receptor activation, we found no evidence of EGF receptor activation in NIH3T3 cells that expressed wt E5 or L24A E5. The discrepancies in the results of these studies may derive from the fact that we analysed E5-dependent activation of endogenous EGF receptors, whereas Martin et al. (1989) employed an NIH3T3 cell line that overexpressed a 40-fold higher level of exogenous human EGF receptors. In agreement with our ®ndings, Goldstein et al. (1994) have shown that only the PDGF-R is functionally activated by E5 in 32D mouse myeloid cells that express equal levels of exogenous PDGF-Rs, EGF receptors and CSF-1 receptors.
The data we have presented indicate that E5-dependent PI 3-K activation, which occurs independently of PDGF-R and Src activation , and this study), is not by itself sucient to induce transformation. L26A E5 does not transform cells that are de®cient for Src (SYF cells), or cells that have basal Src PTK activity (K295R Src overexpressers), even though these cells have persistently activated PI 3-K. We cannot, however, rule out the possibility that constitutively activated PI 3-K is required in combination with constitutively activated Src in order for E5 to transform cells independently of PDGF-R signaling. Since basal PI 3-K activity is required for the long-term viability of cell lines used in this study (unpublished results) , it is clear that transformation requires at least basal PI 3-K activity in combination with elevated Src PTK activity. A dominant-negative mutant of the PI 3-K p85 regulatory subunit (Dhand et al., 1994) may prove useful for reducing PI 3-K activity to a basal level in E5-expressing cell lines, so that E5-dependent transformation can be assessed in cells which possess elevated Src PTK activity and basal PI 3-K activity.
Materials and methods
Cell culture
All cell lines were maintained at 378C in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% FBS, 100 U/ml penicillin G and 100 mg/ml streptomycin sulfate (Life Technologies, Inc.). A Beckman-Coulter particle counter was employed for determinations of cell density.
NIH3T3 cell lines expressing wt BPV-1 E5 and the E5 point mutants Q17G, Q17S, L24A, and L26A have been described previously (Sparkowski et al., 1994; Adduci and Schlegel, 1999; Suprynowicz et al., 2000) . An NIH3T3 cell line expressing v-Src was obtained following geneticin G418 selection of cells co-transfected with v-Src and the neomycin resistance-conferring plasmid, LNCX, at a ratio of 9 : 1 (vSrc DNA : LNCX) by means of CaPO 4 -mediated precipitation (Graham and van der Eb, 1973) . NIH3T3 cells stably expressing L26A E5 and the chicken c-Src point mutant, K295R (Bagrodia et al., 1991) , were generated by cotransfecting L26A E5-expressing cells with K295R c-Src and the retroviral vector pBABEpuro (Morgenstern and Land, 1990) , and selecting in 5 mg/ml puromycin (Calbiochem). A minimum of 20 puromycin-resistant colonies were pooled for use in experiments.
Immortalized mouse ®broblasts de®cient for Src, Fyn and Yes (SYF cells), control cells similarly derived from a normal mouse embryo expressing Src, Fyn and Yes (F wt cells) and SYF cells in which c-Src expression has been reconstituted via the retroviral vector pLXSH (SYF+c-Src cells) were purchased from ATCC, and have been described elsewhere (Klinghoer et al., 1999) . Stable lines expressing L26A E5 and Q17G E5 were generated from these cells as follows: E5 constructs were cloned into the BamHI site of pBABEpuro and transfected into SD3443 cells using Lipofectamine Plus (Life Technologies, Inc.) according to the manufacturer's instructions. Culture supernatants containing retrovirus particles were collected 24 h after transfection and were used to infect SYF, F wt and SYF+c-Src cells, which subsequently underwent selection in 1.5 mg/ml puromycin.
To analyse signal transduction pathways in the absence of growth factor stimulation, 50% con¯uent cultures of NIH3T3 cell lines were washed twice with Dulbecco's phosphate-buered saline (PBS), and were incubated in DMEM containing 0.1% FBS for 24 h at 378C. 85% con¯uent cultures of SYF and F wt cell lines were similarly washed with PBS, and were incubated in DMEM+0.1% FBS for 6 h at 378C. (We found that signi®cant numbers of SYF cells became detached from the tissue culture dish if maintained in 0.1% FBS for 46 h.) Details of our cell proliferation assay have been reported previously . Results are expressed as the per cent increase in number of cells, which is 1006(®nal density ± initial density)/initial density. The PDGF, insulin, EGF, basic FGF and IGF used in this assay were obtained from Life Technologies, Inc.
Transformation assay
The focus forming activities of stable cell lines derived from SYF cells (and SYF+c-Src cells) were assayed by plating 200 cells from these lines together with 1.4610 6 normal NIH3T3 cells in 75 cm 2 tissue culture¯asks containing 20 ml DMEM+10% FBS. Cultures were maintained at 378C for up to 17 days, and were given fresh medium every third day. Foci were stained by treating the¯asks with 1% methylene blue (Sigma) in 100% methanol for 15 min. Flasks were then rinsed with deionized water and allowed to dry at room temperature.
The focus forming properties of stable cell lines derived from NIH3T3 cells were assayed by plating 500 cells from these lines together with 5610 5 normal NIH3T3 cells in 75 cm 2 tissue culture¯asks containing 20 ml medium. After 3 days, the cells were detached (trypsin/EDTA treatment), replated in 175 cm 2 tissue culture¯asks containing 45 ml medium, and maintained at 378C for 17 days with additions of fresh medium every third day.
Immunoprecipitation and Western blotting
Tyrosine-phosphorylated proteins were immunoprecipitated from cell lysates, fractionated by SDS-polyacrylamide gel electrophoresis and transferred to Immobilon-P membranes (Millipore) as described previously . Membranes were labeled in the presence of 2% bovine serum albumin (BSA) and 0.5% (w/v) Triton X-100 as described using polyclonal IgG fractions at 1 ± 2 mg/ml which recognize the PI 3-K 85 kDa subunit, insulin receptor b subunit or EGF receptor (Upstate Biotechnology). The same protocol was used for labeling immunoblots with an anti-FAK monoclonal antibody at 3.5 mg/ml (Upstate Biotechnology), or anity-puri®ed anti-IGF receptor-1 b subunit polyclonal antibody at 0.5 mg/ml (Santa Cruz Biotechnology). For detection of FGF receptors, immunoblots were blocked for 30 min at room temperature in PBS containing 5% nonfat dry milk and 0.05% (w/v) Tween-20, and were labeled overnight at 48C with an anitypuri®ed polyclonal antibody recognizing FGF receptor-1 at 1 mg/ml in blocking solution (Santa Cruz Biotechnology). These membranes subsequently were washed three times with PBS+0.05% Tween-20 (10 min/wash) and labeled for 90 min at room temperature with alkaline phosphatase-linked goat anti-rabbit IgG (Applied Biosystems) diluted 1 : 5000 in blocking solution.
For analysis of E5 expression, E5 was immunoprecipitated from aliquots of cell lysates containing 0.6 mg protein using 10 ml of rabbit antiserum raised against the COOH-terminal 20 amino acids of wt BPV-1 E5 (Schlegel et al., 1986) . Immunoprecipitated E5 was detected on Western blots (2% BSA+0.5% Triton X-100 protocol) using the same antiserum at a dilution of 1 : 5000. The expression of Src was measured directly on Western blots (2% BSA+0.5% Triton X-100 protocol) probed with an anti-Src monoclonal antibody at 2 mg/ml (Upstate Biotechnology; clone GD11). Fyn expression was monitored on Western blots using an anitypuri®ed anti-Fyn polyclonal antibody at 0.4 mg/ml (Santa Cruz Biotechnology) and the 5% nonfat dry milk+0.05% Tween-20 protocol.
Levels of active protein kinase B/Akt (Akt) were measured on Western blots labeled with an anity-puri®ed polyclonal antibody (1 : 1000 dilution) that selectively recognizes Akt which is phosphorylated at S473 (Cell Signaling). PBS+2% BSA was employed for blocking and antibody dilutions, and PBS+0.05% Tween-20 was used for washing.
Kinase assays
PI 3-kinase activity was measured in anti-phosphotyrosine immunoprecipitates essentially as described by Solto et al. (1994) , with minor modi®cations . For assays of Src and Fyn PTK activity, cells from 15-cm tissue culture dishes were washed with 25 ml of PBS containing 1 mM Na 3 VO 4 and were scraped into 1 ml of pY lysis buer (50 mM NaCl, 50 mM NaF, 10 mM Na 4 P 2 O 7 , 5 mM EDTA, 1% (w/v) Triton X-100, 1 mM Na 3 VO 4 , 0.5 mM phenylmethylsulfonyl¯uoride, 2 mg/ml leupeptin, 2 mg/ml pepstatin, 2 mg/ml aprotinin, 50 mM HEPES-NaOH, pH 7.5) at 48C. The lysates were subjected to ultrasonic disruption (2 pulses of 10 s at 48C) using a Sonics and Materials, Inc. apparatus ®tted with a microprobe, and were clari®ed by centrifugation for 5 min at 1000 g. Kinases were immunoprecipitated from aliquots of clari®ed lysate containing 0.4 mg protein (Bio-Rad DC protein assay with bovine IgG standard) by mixing for 90 min at 48C with 4 mg of anti-Src or anti-Fyn antibodies (see above) and 30 ml of protein G-agarose beads (Src) or protein A-agarose beads (Fyn) (Pierce; ImmunoPure Plus). The beads containing bound kinases were washed three times with 1 ml of pY lysis buer (5 min rotating end-overend per wash) and three times with 1 ml of Src kinase assay buer (50 mM KCl, 10 mM EGTA, 2.5 mM MgCl 2 , 1 mM dithiothreitol, 50 mM PIPES-KOH, pH 7.0) at 48C. For each immunoprecipitation, 300-ml aliquots of beads suspended in the ®nal wash were transferred to three siliconized 1.5 ml microcentrifuge tubes, and were centrifuged for 30 s at 1000 g. Two hundred and seventy-®ve ml of supernatant was removed from each tube, and the remaining 25 ml of bead suspension was mixed (at 48C) with an equal volume of Src kinase assay buer containing 200 mM ATP, 0.4 mCi/ml [g-32 P]ATP (ICN) and 500 mM of the peptide KVEKIGEGTYGVVYK (Upstate Biotechnology), which corresponds to amino acids 6 ± 20 of p34 cdc2 and serves as a selective substrate for Src family kinases (Cheng et al., 1992) . Kinase assays were immediately initiated by transferring these tubes to a shaking platform at room temperature, and were terminated after 10 min by centrifuging for 10 s in an Eppendorf microcentrifuge and spotting 25 ml of supernatant on a 2.3-cm Whatman P81 phosphocellulose ®lter. Filters were washed ®ve times with 1% H 3 PO 4 (4 ml/®lter; 5 min/wash) and analysed by liquid scintillation counting (Witt and Roskoski, 1975) . Kinase assays in which the substrate peptide was omitted also were performed for each immunoprecipitation, and the resulting low level of 32 P retained by the phosphocellulose ®lters was subtracted from the level retained when substrate was present. The substrate peptide was prepared as a 1.5 mM stock solution in (50 mM Mg(CH 3 COO) 2 , 10 mM MnCl 2 , 1 mM EGTA, 1 mM dithiothreitol, 100 mM Tris-HCl, pH 7.2) and was stored as single-use aliquots at 7708C.
